Biometrik Riset Indonesia Strengthens Industry Partnerships Through Sponsorship at APSMI Event 2026

Bali, Indonesia – PT Biometrik Riset Indonesia participated as a sponsor at the Asia Pacific Self Medication Industry (APSMI) Event 2026, held in Bali on 29–31 October 2026. This participation reflects Biometrik’s ongoing commitment to strengthening its presence in the pharmaceutical industry and expanding its network of strategic partnerships across the Asia-Pacific region.

As an independent Contract Research Organization (CRO), Biometrik Riset Indonesia continues to build meaningful collaborations with pharmaceutical companies, research institutions, and other industry stakeholders. Through its involvement in industry events such as APSMI, Biometrik aims to foster new business opportunities, strengthen existing relationships, and explore potential collaborations in pharmaceutical research and development.

With a strong focus on clinical trial services, Biometrik is committed to supporting pharmaceutical companies throughout their clinical research journey. By combining scientific expertise, reliable research processes, and a commitment to quality, Biometrik aims to serve as a trusted CRO partner in facilitating the development and evaluation of pharmaceutical products.

Participation in APSMI also provided a valuable opportunity for Biometrik to engage directly with industry professionals, exchange insights, and gain a deeper understanding of the evolving needs and opportunities within the pharmaceutical sector.

Moving forward, Biometrik Riset Indonesia remains dedicated to expanding its strategic partnerships and strengthening its capabilities in clinical research, contributing to the advancement of pharmaceutical innovation both in Indonesia and internationally.

Biometrik Riset Indonesia, Your Trusted Partner in Clinical Research.